Human papillomavirus types by age in cervical cancer precursors

Predominance of human papillomavirus 16 in young women

Carolina Porras, Ana Cecilia Rodríguez, Allan Hildesheim, Rolando Herrero, Paula González, Sholom Wacholder, Robert D. Burk, Mark Schiffman

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

In a population-based study conducted in Guanacaste, Costa Rica, we investigated the human papillomavirus (HPV) types detected in 233 cases of cervical intraepithelial neoplasia (CIN) 2/3 and cancer by age. CIN2+ and CIN3+ in young women were significantly more likely to be associated with HPV 16 than the same lesions in older women (80% of CIN3+ were associated with HPV 16 among women ages 18-26 years compared with only 32% among women older than 55 years; Ptrend = 0.018). There were no differences by age in HPV 18 positivity. Lesions in older women were mainly caused by other carcinogenic types. This association was present for both prevalent and incident lesions and supports the notion that HPV 16 is a stronger carcinogen than other HPV types. It also has implications for prevention, including the need to vaccinate young women before exposure to HPV vaccine-containing types (HPV 16 and HPV 18) to prevent the majority of cervical cancer precursors.

Original languageEnglish (US)
Pages (from-to)863-865
Number of pages3
JournalCancer Epidemiology Biomarkers and Prevention
Volume18
Issue number3
DOIs
StatePublished - Mar 2009

Fingerprint

Human papillomavirus 16
Uterine Cervical Neoplasms
Human papillomavirus 18
Papillomavirus Vaccines
Costa Rica
Cervical Intraepithelial Neoplasia
Carcinogens
Population
Neoplasms

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Human papillomavirus types by age in cervical cancer precursors : Predominance of human papillomavirus 16 in young women. / Porras, Carolina; Rodríguez, Ana Cecilia; Hildesheim, Allan; Herrero, Rolando; González, Paula; Wacholder, Sholom; Burk, Robert D.; Schiffman, Mark.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 18, No. 3, 03.2009, p. 863-865.

Research output: Contribution to journalArticle

Porras, Carolina ; Rodríguez, Ana Cecilia ; Hildesheim, Allan ; Herrero, Rolando ; González, Paula ; Wacholder, Sholom ; Burk, Robert D. ; Schiffman, Mark. / Human papillomavirus types by age in cervical cancer precursors : Predominance of human papillomavirus 16 in young women. In: Cancer Epidemiology Biomarkers and Prevention. 2009 ; Vol. 18, No. 3. pp. 863-865.
@article{2a373937e1f44b0cb7f2f22e869534ca,
title = "Human papillomavirus types by age in cervical cancer precursors: Predominance of human papillomavirus 16 in young women",
abstract = "In a population-based study conducted in Guanacaste, Costa Rica, we investigated the human papillomavirus (HPV) types detected in 233 cases of cervical intraepithelial neoplasia (CIN) 2/3 and cancer by age. CIN2+ and CIN3+ in young women were significantly more likely to be associated with HPV 16 than the same lesions in older women (80{\%} of CIN3+ were associated with HPV 16 among women ages 18-26 years compared with only 32{\%} among women older than 55 years; Ptrend = 0.018). There were no differences by age in HPV 18 positivity. Lesions in older women were mainly caused by other carcinogenic types. This association was present for both prevalent and incident lesions and supports the notion that HPV 16 is a stronger carcinogen than other HPV types. It also has implications for prevention, including the need to vaccinate young women before exposure to HPV vaccine-containing types (HPV 16 and HPV 18) to prevent the majority of cervical cancer precursors.",
author = "Carolina Porras and Rodr{\'i}guez, {Ana Cecilia} and Allan Hildesheim and Rolando Herrero and Paula Gonz{\'a}lez and Sholom Wacholder and Burk, {Robert D.} and Mark Schiffman",
year = "2009",
month = "3",
doi = "10.1158/1055-9965.EPI-08-0951",
language = "English (US)",
volume = "18",
pages = "863--865",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

TY - JOUR

T1 - Human papillomavirus types by age in cervical cancer precursors

T2 - Predominance of human papillomavirus 16 in young women

AU - Porras, Carolina

AU - Rodríguez, Ana Cecilia

AU - Hildesheim, Allan

AU - Herrero, Rolando

AU - González, Paula

AU - Wacholder, Sholom

AU - Burk, Robert D.

AU - Schiffman, Mark

PY - 2009/3

Y1 - 2009/3

N2 - In a population-based study conducted in Guanacaste, Costa Rica, we investigated the human papillomavirus (HPV) types detected in 233 cases of cervical intraepithelial neoplasia (CIN) 2/3 and cancer by age. CIN2+ and CIN3+ in young women were significantly more likely to be associated with HPV 16 than the same lesions in older women (80% of CIN3+ were associated with HPV 16 among women ages 18-26 years compared with only 32% among women older than 55 years; Ptrend = 0.018). There were no differences by age in HPV 18 positivity. Lesions in older women were mainly caused by other carcinogenic types. This association was present for both prevalent and incident lesions and supports the notion that HPV 16 is a stronger carcinogen than other HPV types. It also has implications for prevention, including the need to vaccinate young women before exposure to HPV vaccine-containing types (HPV 16 and HPV 18) to prevent the majority of cervical cancer precursors.

AB - In a population-based study conducted in Guanacaste, Costa Rica, we investigated the human papillomavirus (HPV) types detected in 233 cases of cervical intraepithelial neoplasia (CIN) 2/3 and cancer by age. CIN2+ and CIN3+ in young women were significantly more likely to be associated with HPV 16 than the same lesions in older women (80% of CIN3+ were associated with HPV 16 among women ages 18-26 years compared with only 32% among women older than 55 years; Ptrend = 0.018). There were no differences by age in HPV 18 positivity. Lesions in older women were mainly caused by other carcinogenic types. This association was present for both prevalent and incident lesions and supports the notion that HPV 16 is a stronger carcinogen than other HPV types. It also has implications for prevention, including the need to vaccinate young women before exposure to HPV vaccine-containing types (HPV 16 and HPV 18) to prevent the majority of cervical cancer precursors.

UR - http://www.scopus.com/inward/record.url?scp=64549086045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64549086045&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-08-0951

DO - 10.1158/1055-9965.EPI-08-0951

M3 - Article

VL - 18

SP - 863

EP - 865

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 3

ER -